PARIS--(BUSINESS WIRE)-- Sky9 Capital, a global Asia-rooted technology venture capital firm with approximately $2 billion in assets under management, announced the opening of its Paris office at Station F, Europe's largest startup campus.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260924712927/en/
Ron Cao, Founder and CEO of Sky9 Capital, participating in a panel discussion at VivaTech 2026 in... (continue reading...)
LAKELAND, Fla.--(BUSINESS WIRE)-- Publix Super Markets Charities is making a $500,000 donation to United Way to help fund relief efforts for areas impacted by Hurricane Isaias.
“Hurricane Isaias brought disruption and uncertainty to many of the communities we serve,” said Publix Charities Executive Director John Doran. “Supporting them during times of need is an important part of who we are, and we’re grateful for the opportunity to assist through an organization... (continue reading...)
VIENNA--(BUSINESS WIRE)-- The prpl Foundation highlighted KAON Broadband’s participation in the prpl Summit 2026 as an Innovation Partner for Technical Day and a Technology Partner for Business Day. This partnership underscores KAON Broadband’s continued commitment to advancing open-source broadband platforms, backed by its extensive experience in commercial operator deployments and ongoing development of next-generation connectivity solutions.
This press release... (continue reading...)
Company to Demonstrate Smart Routing, AI Factory Infrastructure and Cloud Services at Booth A3
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- GoodVision AI (“GoodVision”), a developer of next-generation AI compute infrastructure purpose-built for inference, today announced that it will exhibit at TechCrunch Disrupt 2026, taking place October 13–15, 2026, at Moscone West in San Francisco. The appearance follows the September 11 approval of GoodVision’s business... (continue reading...)
Remigromig demonstrated non-inferiority in mean change from baseline in best corrected visual acuity versus ranibizumab at one year in patients with diabetic macular edema (DME)
Remigromig is the first biologic with a novel mechanism of action to demonstrate non-inferior visual acuity compared with anti-VEGF therapy in a pivotal DME trial
Despite available therapies, up to 40% of people with DME have persistent disease after six months, driving need for new... (continue reading...)
More Business Wire
View Older Stories-
Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
-
T-Mobile Crews and Teams Restore Connectivity as Gulf Coast Communities Recover from Hurricane Isaias
-
Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
-
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 2026
-
AHF Debuts ‘Wellness on Wheels’ - New EV Mobile Clinic During ‘Pride on Paradise’
-
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities
-
General Mills Announces Pricing Terms, Expiration and Results of Cash Tender Offers for its Senior Notes
-
CBRE Global Real Estate Income Fund (NYSE: IGR) Declares Monthly Distributions for October, November and December and Announces a Webinar with Portfolio Management
-
Blueberry Medical (“Blueberry”) Security Incident
-
Hudson Pacific Properties Announces Expiration and Tender Results of Cash Tender Offer for Outstanding Notes
-
LibertyStream Updates Shareholder Meeting Timing
-
Service Properties Trust Confirms Receipt of Unsolicited Proposal for Hotel Portfolio From TKO Hotels
-
Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompro
-
Network of Giving Lifts Off in Seattle and Edmonton
-
'Pride on Paradise' Festival Returns Oct. 10 with Plastique Tiara, Adore Delano, Juicy Love Dion, and More
-
ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset
-
IPA Capital Markets Arranges $50 Million in Financing for 18-Property Industrial Portfolio
-
FCPT Announces Acquisition via Sale-Leaseback of an Automotive Service Property for $2.3 Million
-
KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2026-CES10 (RCKT 2026-CES10)
-
Exchange Income Corporation to Host Third Quarter Results Conference Call on November 13, 2026
-
Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting
-
JPMorganChase to Present at the BancAnalysts Association of Boston Conference
-
Absolute Security Acquires Phoenix Technologies’ FirmGuard to Build on the Firmware Foundation Enterprises Need for Secure, Compliant, and Resilient AI
-
Arcus Biosciences Announces New Employment Inducement Grants
-
Radian to Webcast Third Quarter Conference Call
-
CrowdStrike Recommends Stockholders Reject the “Mini-Tender” Offer by Tutanota LLC
-
Comtech To Host Fourth Quarter and Fiscal Year 2026 Earnings Conference Call
-
Mettler-Toledo International Inc. to Host Third Quarter 2026 Earnings Conference Call
-
Ryder Declares Quarterly Cash Dividend
-
LionShares Announces Liquidation of TOT
-
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
-
UiPath Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Agentic Software Quality Assurance Platforms
-
NTT DATA Expands Global Cyber Defense Footprint With New Operations Center in North Texas
-
Virtus Investment Partners to Announce Third Quarter 2026 Financial Results on Friday, October 30
-
DWS Municipal Income Trust Declares Monthly Distribution
-
McGraw Hill, Inc. Announces Successful Completion of Refinancing Transactions
-
BigBear.ai to Report Third Quarter 2026 Results on October 27, 2026
-
Over 70 people rally in support of Thunder Bay library workers: ‘If you have to strike, we’ll be with you on the picket line’
-
Duff & Phelps Utility and Infrastructure Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
-
DNP Select Income Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
RLI Announces Leadership Promotions
-
Enterprise Financial Services Corp Announces Third Quarter 2026 Earnings Release and Conference Call
-
River City Bank Announces Date for Third Quarter 2026 Earnings Release and Webcast
-
NYSE Group Consolidated Short Interest Report
-
CareTrust Publishes Sixth Annual Corporate Sustainability Report
-
Celanese Announces Polyamide Price Increase
-
SBSB Partners Singled Out for Excellence in Corporate Employment Law
-
Agenus to Participate in Chardan’s 10th Annual Healthcare Investor Conference
